Background: Lipocalin-2 (LCN2) is widely expressed in the organism with pleiotropic roles. In particular, its overexpression correlates with tissue stress conditions including inflammation, metabolic disorders, chronic diseases and cancer. Objectives: To assess the effects of systemic LCN2 overexpression on adipose tissue and glucose metabolism. Subjects: Eighteen-month-old transgenic mice with systemic LCN2 overexpression (LCN2-Tg) and age/sex-matched wildtype mice. Methods: Metabolic cages; histology and real-time PCR analysis; glucose and insulin tolerance tests; ELISA; flow cytometry; microPET and serum analysis. Results: LCN2-Tg mice were smaller compared to controls but they ate (P = 0.0156) and drank (P = 0.0057) more and displayed a higher amount of visceral adipose tissue. Furthermore, LCN2-Tg mice with body weight ≥20 g showed adipocytes with a higher cell area (P < 0.0001) and altered expression of genes involved in adipocyte differentiation and inflammation. In particular, mRNA levels of adipocyte-derived Pparg (P ≤ 0.0001), Srebf1 (P < 0.0001), Fabp4 (P = 0.056), Tnfa (P = 0.0391), Il6 (P = 0.0198), and Lep (P = 0.0003) were all increased. Furthermore, LCN2-Tg mice displayed a decreased amount of basal serum insulin (P = 0.0122) and a statistically significant impaired glucose tolerance and insulin sensitivity consistent with Slc2a2 mRNA (P ≤ 0.0001) downregulated expression. On the other hand, Insr mRNA (P ≤ 0.0001) was upregulated and correlated with microPET analysis that demonstrated a trend in reduced whole-body glucose consumption and MRGlu in the muscles and a significantly reduced MRGlu in brown adipose tissue (P = 0.0247). Nevertheless, an almost nine-fold acceleration of hexokinase activity was observed in the LCN2-Tg mice liver compared to controls (P = 0.0027). Moreover, AST and ALT were increased (P = 0.0421 and P = 0.0403, respectively), which indicated liver involvement also demonstrated by histological staining. Conclusions: We show that LCN2 profoundly impacts adipose tissue size and function and glucose metabolism, suggesting that LCN2 should be considered as a risk factor in ageing for metabolic disorders leading to obesity.
Introduction
Lipocalin-2 (LCN2) belongs to a superfamily of more than 20 proteins identified originally in human neutrophil granules [1, 2] . Lipocalins bind a wide array of small hydrophobic ligands, which include bacterial siderophores [3] . LCN2 is involved in innate immunity and regulates several cellular processes. It is expressed in several tissues and overexpressed during tissue stress conditions like postpartum uterus involution [4] . In the skeleton, LCN2 is expressed by chondrocytes in the hypertrophic cartilage of the growth plate of long bones, which undergo endochondral ossification [5] , and by differentiating osteoblasts along with its receptor [6] .
LCN2 is widely overexpressed under pathological conditions such as liver and lung inflammation [7] where macrophages and cells of the immune response produce a large amount of this protein, which correlates with cirrhosisdependent liver failure [8] . Moreover, LCN2 overexpression in the organism actively participates in several disorders and diseases. When overexpressed in mice bones, LCN2 can unbalance the finely tuned bone turnover and modify the bone marrow environment [9] . In chronic kidney disease, Lcn2 overexpression seems to play an active role in causing the renal phenotype [10] . In ovarian [11] , pancreatic [12] , and breast cancers [13] , LCN2 is an important pro-survival protein.
Among the pathological conditions in humans, obesity has increased at an alarming rate in the past 20 years, thus becoming a major health and economic issue for industrialized countries, mainly due to its high number of complicating diseases [14] . For this reason, clinical interest on adipose tissue has been rapidly developing, and thanks to recent studies, this tissue is no longer believed to have uniquely a lipid-storage capability but it is recognized as a diffused endocrine organ meant at producing hormones and cytokines [15] . The latter, when found within adipocytes, are also termed adipokines and play a dramatic role in the modulation of the adipose tissue response, linking obesity to inflammation. An inflammatory state is associated with the current pandemic of obesity and it is an important pathogenetic factor that contributes to the increased prevalence of the so-called metabolic syndrome [16, 17] . Nowadays, it is a common opinion that LCN2 is endowed with pro-inflammatory and metabolism-disrupting properties [18] . Furthermore, recent studies suggest that this protein is an independent risk factor for both inflammation and insulin resistance before diabetes onset. Overall, LCN2 is recognized as one of the adipokines playing a role in obesity and metabolic disorders [19] .
Although recent studies reported a correlation between serum LCN2 concentration, glucose metabolism alterations and inflammatory markers [16] , the underlying mechanisms remain largely undefined. In particular, ablation of LCN2 expression has been found to only marginally improve obesity-associated glucose intolerance without affecting either age-or obesity-mediated insulin resistance [19] . Moreover, a recent report suggested that bone-derived LCN2 regulates metabolism by suppressing appetite through Mc4r in the hypothalamus, thus assigning a leading role to LCN2 in bone endocrine function [20] .
In this scenario, a better knowledge about LCN2 effects at the organism level is crucial for the understanding of the pathogenesis of metabolic disorders and possibly to open up new paths for therapeutic approaches.
In the present study, we took advantage of a transgenic mouse model overexpressing Lcn2 under the control of the mouse pro alpha 1 type I collagen (Col1A1) gene promoter, which was previously generated in our laboratory [21] . In this mouse model, LCN2 is overexpressed by osteoblasts and released in the blood and therefore this model is suitable to study LCN2 pleiotropic role at the whole-organism level.
In 18-month-old LCN2-Tg mice, we observed an increased expression of some relevant genes linked to obesity such as Lep, Fabp4, Tnfa, and Il6 along with altered glucose tolerance and insulin sensitivity. Moreover, LCN2 overexpression altered glucose metabolism and it was associated with a large increase in adipose tissue volume, food, and water intake. LCN2-Tg mice liver displayed a higher accumulation of lipid droplets correlating with higher serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels.
These data point to LCN2 increased expression as a promoting factor for the development of metabolic disorders in ageing.
Materials and methods

Animal maintenance and generation of LCN2-Tg mice
All procedures involving animals have been approved by Institutional Animal Welfare Body (O.P.B.A.) and respect the national current regulations regarding the protection of animals used for scientific purpose (D.Lvo 4 marzo 2014, no. 26, legislative transposition of Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes). Mice were bred and maintained at the Institution's animal facility (IRCCS AOU -San Martino -IST, Genova, Italy). LCN2-Tg mice were generated as previously described [21] . Mice were maintained on a standard diet (with raw protein 18.5%, raw fats and oils 3.0%, Mucedola s.r.l., Milan, Italy). All analyses were performed on 18-month-old mice.
Metabolic analysis
Food and water consumption were measured in LCN2-Tg and wild-type (Wt) control mice that were weighed and housed for 24 h in metabolic cages.
Histology
For standard histology, Wt and LCN2-Tg liver and visceral fat were isolated and fixed immediately in 4% buffered formaldehyde (Sigma Aldrich). After dehydration in a progressive series of ethanol, fat samples were clarified in xylene and paraffin embedded. Five-µm sections were obtained and stained with hematoxylin and eosin (H&E) for histological examination. Adipocytes were counted in fat sections from Wt and LCN2-Tg mice and surface area was measured using the image analysis software ImageJ (NIH, USA). Each count represents the mean value of five different blinded fields.
To detect lipid accumulation in the liver, the Oil Red O staining was performed. Wt and LCN2-Tg median liver lobes were washed in 1% phosphate-buffered saline (PBS), fixed overnight with 4% paraformaldehyde, and frozen in cryostat embedding medium (Bio-optica) by immersion in liquid nitrogen and stored at −20°C. Eight-μm sections were obtained and stained with Oil red O solution (SigmaAldrich). After washing, nuclei were counterstained with H&E. Diameters of lipid droplets were analyzed by the Huygens software (Scientific Volume Imaging b.v., The Netherlands).
At least five tissue sections were analyzed for each animal. Images were acquired by an Axiovert 200M microscope (Zeiss, Germany).
Adipose and liver macrophage immune profiling
After 8 h of starvation, mice were sacrificed and visceral fat and liver were dissected, minced into small pieces (2-6 mm 3 ), and digested in buffer isolation solution (PBS w/o Ca 2+ and Mg 2+ , 1.5% fetal bovine serum, Collagenase I 1 mg/ml). The homogenized suspensions were maintained in a water bath at 37°C with intermittent shaking for 1.5 h and then passed through a seven-µm nylon mesh. The cell suspension was centrifuged at 400 × g for 10 min at 25°C and then washed in RPMI1640 medium. 
Real-time PCR analysis
Visceral, brown adipose tissue (BAT) and liver samples from mice were isolated and homogenized in Qiazol reagent (Qiagen). Subsequently, samples were extracted by the RNeasy Plus Mini Kit (Qiagen). All samples were then quantified by optical density measurement and checked for quality (NanoDrop 1000 Thermo Scientific). cDNA synthesis was performed using the Omniscript Reverse Transcription Kit (Qiagen). Real-time PCR reaction was performed using specific primers for each gene (Table S1 ) and Platinum SYBR green qPCR SuperMix-UDG with ROX Kit (Invitrogen). Detection was performed using the 7500 fast real-time PCR system (Thermo Fisher Scientific). Relative expression values with standard errors were obtained using the Thermo Fisher Scientific software and normalized to the expression of the housekeeping gene Hprt. Each sample was run in triplicate.
Glucose tolerance test (GTT)
After a short fasting time (6 h), mice were intraperitoneally (IP) injected with glucose solution (1.5 mg/g). Glucose concentrations were measured by the COMFORT Lux GD50 system (Fora, BC Trade Medical Technology) before glucose administration (time 0) and monitored at different time points after the injection [22] .
Insulin tolerance test (ITT)
After a short fast (6 h), mice were IP injected with an insulin bolus at a concentration of 0.75 U/Kg. Glucose concentrations were measured before the insulin administration (time 0) and monitored at different time points after the injection [22] .
Micro-positron emission tomographic (microPET) analysis
In vivo imaging was performed according to a protocol validated in our lab [23] [24] [25] . Before PET scan, mice were kept under fasting conditions with free access to water for 6 h. Mice were weighted and anesthesia was induced by IP administration of ketamine (100 mg/kg) and xylazine (10 mg/kg) (Imalgere 1000 and Bio98 Srl, Milan, Italy, respectively). Animals were positioned on the bed of a dedicated microPET system (Albira, Bruker, Billerica, MA, USA), the double-ring configuration of which permitted to cover the whole animal body in a single bed position. A dose of 3-4 MBq of 18F-fluorodeoxyglucose (FDG) was then injected through a tail vein, soon after the start of a list mode acquisition lasting 50 min.
The whole dataset was thus binned using the following framing rate: 10 × 15 s, 5 × 30 s, 2 × 150 s, 6 × 300 s, 1 × 600 s. PET data were reconstructed using a maximal likelihood expectation maximization method. An experienced observer, kept unaware of the experimental type of the analyzed model, identified a volume of interest (VOI) in . e Metabolic cages' analysis for food and water intake (LCN2-Tg N = 18; Wt N = 18). Results are means ± SEM. Data were analyzed with Student's t test. *P < 0.05, **P < 0.01, ***P < 0.001 the left ventricle. The time-concentration curve within this VOI throughout the whole acquisition was plotted and defined the arterial tracer input function. Whole-body FDG clearance (in ml/min) was calculated, using the conventional stochastic approach, as the ratio between injected dose and integral of input function from 0 to infinity, fitting the last 20 min with a mono-exponential function [26] . This value was thus multiplied by serum glucose level to measure whole-body glucose consumption and then normalized based on body weight and thus expressed as µM/min/100 g. Thereafter, all dynamic scans were processed according to the Gjedde-Patlak [27] graphical approach to compartmental analysis by using the routine of a dedicated software (PMOD, Zurich, Switzerland). Briefly, the software utilizes Results are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 the input function and transforms the original tissue activity measurements by fitting the data in each voxel with the slope of the regression line defined by the model. In all cases, the lumped constant value was set at 1. On the obtained parametric maps, three further VOIs were drawn to estimate metabolic rate of glucose (MRGlu) in BAT and in hind limb skeletal muscles (SM).
Liver FDG kinetics was assessed according to a method previously validated in our laboratory [26] . Briefly, the algorithm utilizes time-concentration curve in the gut to derive portal vein input function and provides a description of parameters quantifying the rate of hexokinase-catalyzed glucose phosphorylation (k mf ) as well as the rate of G6P-phosphatase catalyzed dephosphorylation (k fm ) of FDG within hepatocytes.
Serum analysis
Mice were sacrificed after a 6 h of fasting to allow cardiac blood samples collection. Samples were centrifuged for 60 min at 7500 × g and then stored at −80°C. Glucose, urea, creatinine, triglycerides, total bilirubin, bile acids, AST, and ALT were assayed in serum (all Mindray reagents) using a clinical-standard automatic chemistry analyzer (BS-380 Mindray).
Enzyme-linked immunosorbent analysis (ELISA)
After a short fast (6 h), mice were IP injected with a glucose solution (1.5 mg/g). Insulin concentrations were measured before the glucose administration and after 15 min and 1 h postinjection. Blood samples were collected by the tail vein and following 60 min clotting, samples were centrifuged 60 min at 7500 × g and then stored at −80°C until ready for analysis. Serum insulin levels were determined by ELISA (Mouse insulin ELISA, Mercodia AB, Uppsala, Sweden). The absorbance was measured in a Victor X Perkin Elmer (Waltham, MA, USA) at 450 nm and the insulin concentration in experimental samples was calculated from a standard curve.
Statistical analysis
Data were expressed as mean ± SEM and analyzed using the GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA). Statistical analysis was performed by a twotailed t test.
The sample size was chosen considering, for all the experiments, a statistical power of 0.8, a standard deviation (SD) of 50%, and a type I error rate of 0.05.
We analyzed the variance using variance ratio test. The variance between the two groups of animals were not statistically significantly different (P = 0.189).
Results
LCN2-Tg mice weight and metabolism
To investigate the role of LCN2 in the control of body weight, fat accumulation in the adipose tissue, and food and water intake, we used a transgenic mouse model that overexpresses LCN2 in the serum [21] . As previously reported [6] , we found that LCN2-Tg mice displayed a smaller body size and weight compared to Wt controls (Fig. 1a) . Furthermore, LCN2-Tg mice showed a higher amount of visceral fat per body weight (Fig. 1b, c) . To assess the levels of the Lcn2 mRNA in the adipose tissue, we performed a real-time PCR analysis. This analysis showed that the Lcn2 mRNA was expressed at much higher levels in the adipose tissue of LCN2-Tg mice compared to Wt (P < 0.001) (Fig. 1d) . Despite their lower body mass and size, LCN2-Tg showed higher food (P = 0.0156) and water (P = 0.0057) intake (Fig. 1e ).
Physiology and inflammatory status of LCN2-Tg mice visceral adipose tissue
To better characterize the LCN2-Tg visceral adipose tissue, we performed histological and molecular analyses (Fig. 2) . Mice necropsy confirmed a higher amount of visceral adipose tissue in LCN2-Tg (Fig. 2a) and the related H&E staining showed no major leucocytes infiltration. However, this analysis also revealed in the adipose tissue of those LCN2-Tg with a body weight >20 g a lower total number of adipocytes compared to Wt controls (P = 0.0001; Fig. 2b) . Furthermore, the adipocytes in these LCN2-Tg mice, showed a higher degree of hypertrophy as they displayed a larger mean cellular area (P < 0.0001; Fig. 2c) .
From these results, we hypothesized an aberrant expression of genes involved in adipocyte differentiation, inflammation, and body weight control. Therefore, we performed a real-time PCR analysis on adipose tissue in randomly selected Wt and LCN2-Tg mice.
In particular, we evaluated mRNA levels for Pparg and Srebf11, two relevant proteins expressed during adipocyte differentiation [28] and the mRNA levels for the Fabp4 (fatty acid-binding protein) and Lep, which are involved in both obesity and metabolic syndrome [29] . Figure 2d , e show that these mRNAs were all significantly upregulated in LCN2-Tg adipose tissue compared to Wt: Pparg (P < 0.001); Srebf1 (P < 0.001); Fabp4 (P = 0.0056); Lep (P = 0.0003).
Since obesity often correlates with increased circulating inflammatory adipokines, we studied by real-time PCR analysis the expression of the pro-inflammatory cytokines, e.g., Tnfa and Il6 mRNAs in the adipose tissue of randomly selected mice. This analysis revealed a significantly increased expression of both Tnfa (P = 0.0391) and Il6 transcripts (P = 0.0198) in LCN2-Tg mice compared to controls (Fig. 2e) .
Fat-resident macrophages are major players in the modulation of the inflammatory microenvironment within the adipose tissue [30] . To assess whether LCN2 affects the presence of these cells in the adipose tissue, we measured by fluorescence-activated cell sorting analysis the percentage of inflammatory M1 and anti-inflammatory M2 macrophages, identified by the expression of CD86 and CD206, respectively. This analysis showed similar percentage of fatresident M1 and M2 macrophages in LCN2-Tg and Wt mice (Fig. 2f) .
Glucose homeostasis in LCN2-Tg mice
Given the alterations found in the LCN2-Tg mice adipose tissue, we hypothesized the presence of alterations in glucose homeostasis in these mice. Therefore, we performed an IP GTT, which showed no differences between the Wt and LCN2-Tg mice in the starting and final values of glucose concentration (Fig. 3a) . However, a relative delay in the glucose downward slope occurred in LCN2-Tg mice, with a significantly higher glucose levels attained at 30 min (P = 0.032) and 60 min (P = 0.0171) after glucose IP injection. This data prompted us to analyze glucose after insulin IP injection (ITT). Animals were fasted for 6 h and glucose concentration was measured before insulin administration (0.75 U/Kg) and every 10 min up to 1 h thereafter. A significant and dramatic decrease of serum glucose level in LCN2-Tg mice compared to controls after IP insulin administration was observed (Fig. 3b) . The observed hormonal hypersensitivity demonstrated that the administered hormone was able to induce a hypoglycemic response and that a hypoinsulinemia condition could be responsible of the GTT and ITT abnormalities. Results are means ± SEM. *P < 0.05, ***P < 0.001, ****P < 0.0001
To test this hypothesis, after a short fast (6 h), Wt and LCN2-Tg mice received a IP glucose injection and were sacrificed to collect cardiac blood samples in order to evaluate the serum insulin levels. We observed indeed a significant reduction of insulin levels in LCN2-Tg mice compared to controls at time 0 while no differences were found after 15 and 60 min from the glucose injection (Fig. 3c) .
These data suggested a complex scenario concerning the glycemic control in LCN2-Tg mice. On one hand, we e Phosphorylation (k mf ) and f dephosphorylation rate (k fm ) of FDG in hepatocytes. Results are means ± SEM. **P < 0.01 observed lower fasting serum insulin levels along with a slower glucose serum clearance compared to controls and, on the other hand, a faster glucose clearance after exogenous insulin administration. This scenario could be, at least in part, explained with lower glucose receptor sensitivity accompanied with higher insulin receptor levels and/or activity. To confirm this hypothesis, we investigated by real-time PCR the transcript levels for Slc2a2, Slc2a4, and Insr. This analysis revealed that the mRNA for the lowaffinity glucose carrier Slc2a2, which is believed to be functioning as glucose sensor, was indeed reduced in LCN2-Tg, whereas the Insr mRNA was increased. Interestingly, the mRNA levels for the high-affinity glucose carrier Slc2a4 were very similar between LCN2-Tg and control mice (Fig. 3d) .
Glucose metabolism analysis by microPET
GTT suggested that LCN2 overexpression might slow down glucose transfer from blood to tissues. To test this hypothesis, we performed a microPET analysis (Fig. 4) . While the whole-body glucose consumption did not show significant differences between LCN2-Tg and Wt mice, LCN2-Tg mice showed a trend (P = 0.0512) in the reduction of MRGlu in SM (Fig. 4c) and a significant reduction in the BAT (P = 0.0247) (Fig. 4d) . Therefore, LCN2 overexpression, from one side, maintained in LCN2-Tg the same concentration of basal blood glucose level of Wt, from the other side, significantly impaired tissue glucose utilization. This paradoxical mismatch was explained by the effect of LCN2 overexpression on liver response to the 6 h fasting preceding microPET imaging. LCN2-Tg mice, indeed, showed an almost nine-fold acceleration of hexokinase activity (k mf ) with respect to Wt ones (P = 0.0027; Fig. 4e ). The abnormal activation of glucose entrapment mechanism was further associated with a slight (though not significant) deceleration in G6P-phosphatasedependent dephosphorylation (k fm ) (Fig. 4f) . Moreover, the relative reduction in FDG uptake of BAT might suggest a reduced thermogenesis in LCN2-Tg mice. To verify this hypothesis, we analyzed Ucp1, Dio2, Elovl3, and Cidea gene expression by real-time PCR. The mRNA levels of the thermogenic markers Ucp1 and Dio2 in LCN2-Tg mice in the interscapular fat did not show significant changes compared to Wt while Elovl3 and Cidea transcript levels showed an increase and a decrease, respectively ( Figure S1 ).
Serum analysis
Glucose homeostasis alteration and visceral adipose tissue accumulation are closely associated with obesity [29] . This disease is characterized by dyslipidemia and a low inflammatory state that in humans is often associated with other Results are mean ± SEM. *P < 0.05, **P < 0.01 serum parameter alterations. In our LCN2-Tg mice, total cholesterol was significantly lower (P = 0.0193) (Fig. 5a) , while triglyceride levels were reduced in comparison to Wt, even if not reaching statistical significance (Fig. 5a ). We could not find any relevant differences in serum creatinine (Fig. 5b) , bile acids (Fig. 5c) , or in total bilirubin levels between the two mice groups (Fig. 5d) . By contrast, in LCN2-Tg mice we found increased serum urea (P = 0.0025) (Fig. 5e) , AST, and ALT levels (P = 0.0421) (Fig. 5f ).
Liver analysis
To investigate whether the higher levels of serum AST and ALT found in LCN2-Tg mice resulted from a liver alteration, we performed histological analysis of this tissue. In particular, we detected by H&E analysis smaller nuclei and a cytoplasmic staining, which was reminiscent of lipid droplets accumulation in LCN2-Tg mice (Fig. 6a, b) . The staining with Oil Red O indeed showed accumulation of lipid droplets in the liver of LCN2-Tg mice (Fig. 6c, d ). To assess whether an inflammatory infiltrate occurred in the liver of LCN2-Tg mice, we analyzed liver macrophages by flow cytometry (FCM). We found that, although both M1 and M2 subpopulations were slightly increased in the liver of LCN2-Tg mice, this difference was not statistically significant (Fig. 6f) .
Discussion
LCN2 is expressed in several tissues and its overexpression is linked to several pathological conditions. However, the exact molecular mechanisms at the basis of the LCN2 effects in different organs and tissues are not clear yet. LCN2-Tg mice, which were generated in our laboratory, overexpresses LCN2 by osteoblasts, which is released in the blood [6] . Therefore, this mouse model is a useful tool to investigate the effects of the upregulation of LCN2 expression in the whole organism, and in a previous report, our group assessed the effects of persistent LCN2 overexpression on bone physiology [6, 9] . In particular, we found in LCN2-Tg mice bone loss, bone marrow modifications, and hematopoietic changes.
Here we show that, in aged mice, a persistent and systemic LCN2 overexpression affects body weight and glucose metabolism. LCN2-Tg mice showed higher amount of visceral adipose tissue, and among them, those >20 g displayed larger adipocytes than controls. Several evidences show that obesity is characterized by enlarged adipose tissue with increased production of both LCN2 and other proinflammatory adipokines, including tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1, and Resistin [31] , which are strongly linked to metabolic abnormalities [29] . Our real-time PCR analysis, performed on adipose tissue of randomly selected LCN2-Tg mice, showed that, besides the expected overexpression of Lcn2 mRNA, the transcripts for two pro-inflammatory adipokines, Tnfa and Il6, were also upregulated in these mice. These data show that the adipose tissue in LCN2-Tg mice developed an inflammatory obese-like phenotype. However, as we could not detect by histology and FCM analyses neither a relevant infiltration by immune cells nor changes in the ratio between M2 pro-inflammatory and M1 anti-inflammatory macrophages, we hypothesize that LCN2 exerts its proinflammatory effects mainly through adipocytes. Real-time PCR analysis also revealed that, Pparg, Srebf1, Lep, and Fabp4 mRNAs were all dramatically upregulated in LCN2-Tg adipose tissue. Leptin is a hormone, which contributes to energy balance regulation by inhibiting hunger [32] through its hypothalamic arcuate nucleus receptors [33] . In obesity, a decreased sensitivity to leptin occurs [34] along with a positive correlation between obesity and high systemic leptin levels [35] . In view of these reports, our data strongly suggest the existence of leptin resistance in LCN2-Tg mice, which, despite a smaller body size, have higher food and water intake compared to Wt mice. Furthermore, the increase in Pparg and Srebf1 mRNAs strongly suggests a high metabolic activity of fat tissue in LCN2-Tg as these genes are very active during adipocyte differentiation and upregulated in cardiovascular and metabolic abnormalities [36] [37] [38] .
LCN2 has pleiotropic roles and its effects depend on dose and timing of stimulation, cell-type target, and its ironbinding status [39] [40] [41] . In literature it has been described that LCN2 deficiency ameliorates dietary-or geneticinduced obesity, which is in line with our data [42] . On the contrary, Mosialou et al. [20] described LCN2 as a protein that suppresses appetite, which contrasts with our data and those by Guo H et al. [42] that did not find food intake modifications in Lcn2−/−. We believe that the contrasting effects observed in LCN2-Tg mice and those observed by Mosialou et al. may originate from different experimental conditions. In particular, we cannot rule out that the different genetic background of the mice model used may affect the results. In our study, we used FVB mice, whereas Mosialou et al. used the C57Bl6 mice. Furthermore, constitutive LCN2 overexpression in Tg mice may activate molecular pathways that are not normally activated in physiological conditions. Obesity has effects on glucose tolerance, which is often decreased in this condition. A slightly improved glucose tolerance was found in high-fat-diet-fed mice with Lcn2 deficiency without any differences in insulin sensitivity [19] . A different study suggested that Lcn2-deficient animals had deleterious diet-related effects, including dyslipidemia, fatty liver disease, insulin resistance, and lower mitochondrial oxidative capacity [42] . In our mice overexpressing LCN2, we observed a complex scenario showing at the same time: slower transfer of glucose from blood to tissues, increased response to exogenous insulin, and reduced fasting insulin levels. Our finding of reduced glucose sensor Slc2a2 mRNA levels, increased liver hexokinase activity, and increased Insr mRNA levels may explain these observation. In particular, reduced glucose sensor levels (Slc2a2) may impair/slow GTT after glucose administration while the increased insulin receptor levels could be responsible for the microPET results and the increased liver hexokinase activity, by promoting the conversion of glucose in the intracellular-bound 6-phosphoglucose. The high expression of insulin receptors in the liver of LCN2-Tg mice agrees with the evident increase in glucose phosphorylation observed in the liver, since one of the most acknowledged actions of insulin on the liver tissue is to facilitate glycogen synthesis. Liver histological analyses showed hepatocytes' morphological alterations. In particular, albeit LCN2-Tg mice do not develop overt liver steatosis, they do have an increase in liver lipid droplets. We suggest that this lipid accumulation may result from the increased Insr mRNA levels and hexokinase activity in the liver of LCN2-Tg mice. In turn, this accumulation may cause the observed higher levels of circulating ALT and AST. In this regard, it is interesting that a previous study reported that LCN2 is a major factor leading to metabolic liver alterations [38] . Liver FCM analysis confirmed the absence of infiltrating macrophages, which was confirmed by the histological analysis.
Because high FDG uptake is frequently observed in wintertime [43] , the reduced tracer retention observed in LCN2-Tg mice could indicate a reduced thermogenesis.
Although LCN2-Tg and Wt mice were studied in the same days and in the same lab, we aimed to verify this hypothesis, analyzing Ucp1, Dio2, Elovl3, and Cidea gene expression. As some of these genes were found not consistently deregulated, further studies are needed to establish whether LCN2-Tg have alterations in thermogenesis. It should also be taken into account that the metabolic alterations observed in LCN2-Tg mice may also depend from osteoblasts that contribute to the energy metabolism through the expression of their own endocrine signals, including osteocalcin, a peptide involved in insulin secretion/sensitivity and energy expenditure regulation [44] . In particular, we previously observed in LCN2-Tg mice bone decreased amounts of osteocalcin mRNA that may contribute to the observed changes in glucose metabolism [6] . Further studies are also required to determine the mechanistic link between LCN2 overexpression, reduced Slc2a2, and increased Insr mRNA expression.
In conclusion, here we show that LCN2 dramatically impacts adipose tissue size and function and glucose metabolism, suggesting that LCN2 should be considered as a risk factor for metabolic disorders leading to obesity.
